U.S. Animal Health Market to Grow with a CAGR of 8.01% through 2030
Increasing pet ownership and rising demand for
animal-derived food products, is expected to drive the U.S. Animal Health
Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “U.S. Animal Health Market – By Region, Competition, Forecast & Opportunities, 2030F”, the U.S. Animal Health Market stood
at USD 12.53 Billion in 2024 and is expected to reach USD 19.92 Billion by 2030
with a CAGR of 8.01% during the forecast period. The U.S. Animal Health Market is experiencing strong growth
due to the increasing demand for innovative healthcare solutions for pets and
livestock. As more people adopt pets and recognize the importance of their
well-being, there has been a rise in the usage of preventive healthcare
products such as vaccines, diagnostics, and specialty treatments. Pet owners
are increasingly seeking advanced veterinary care, contributing to higher
expenditure on treatments and overall animal health services. This shift in pet
care culture, alongside advancements in veterinary medicine, has fostered a
dynamic market with a broad range of services and products aimed at improving
pet health outcomes.
In
the livestock sector, the growing global demand for animal-based food products
is driving the need for improved animal health management. Efficient disease
control, better nutrition, and innovative breeding practices are becoming
essential to ensure sustainable meat and dairy production. Farmers are
leveraging modern technologies, including precision livestock farming, to
monitor and manage animal health more effectively. The ongoing focus on
biosecurity and disease prevention in agriculture is creating significant
growth opportunities for animal health companies that specialize in
diagnostics, vaccines, and therapeutics. These trends reflect a shift toward
more scientifically informed and sustainable practices within the industry.
Growth
opportunities within the U.S. Animal Health Market are significant,
particularly in the areas of telemedicine, digital health technologies, and the
increasing trend of personalized animal care. The adoption of wearable devices
for pets and the integration of artificial intelligence in diagnostics and
treatment plans are expected to revolutionize the industry. In addition, there
is growing interest in the development of biologics, such as vaccines and
monoclonal antibodies, to address both chronic and infectious diseases in
animals. The rise in demand for natural, organic, and specialized pet food
products presents another opportunity for market expansion. These innovations,
coupled with a heightened focus on animal welfare, are expected to propel the
market forward in the coming years.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"U.S. Animal Health Market”
The U.S. Animal
Health Market is segmented into product, animal type, route of administration, disease,
distribution channel, regional distribution, and company.
Based on the Product,
Biologics emerged as the fastest growing segment in the U.S. Animal Health
Market during the forecast period. This is due to their significant advancements in treating a wide
range of animal diseases and their ability to offer more targeted, effective
solutions. These products, including vaccines, monoclonal antibodies, and gene
therapies, provide key benefits over traditional pharmaceuticals, particularly
in terms of precision and safety. Biologics are increasingly being used in both
companion animals and livestock to prevent and treat infectious diseases, with
vaccines playing a pivotal role in controlling outbreaks and reducing the
reliance on antibiotics. This shift is driven by growing concerns over
antimicrobial resistance (AMR), prompting the animal health industry to focus
on alternatives that minimize the use of antibiotics and hormones. The rise in
chronic diseases, such as cancer and arthritis in pets, is also fueling demand
for biologics, which offer more personalized and long-term treatment options.
Additionally, the growing emphasis on animal welfare, better disease
management, and the continuous evolution of biotechnology are contributing
factors to the rapid expansion of biologics in the market. The success of
biologics in improving animal health outcomes and their ability to address
unmet medical needs in the animal health sector make them a key area of growth
for the industry during the forecast period.
Based
on the Region, West region emerged as the fastest growing region in the U.S.
Animal Health Market
during the forecast period.
This is due to a combination of factors, including the high concentration of
pet ownership, a thriving livestock industry, and increasing investments in
animal health research and technology. The region is home to many pet owners,
particularly in states like California, where there is a strong emphasis on the
well-being of animals and an increased demand for preventive healthcare
products. This has driven growth in the pet health sector, with pet owners
seeking advanced veterinary care, medications, and wellness products.
Additionally, the West region has a significant agricultural presence,
particularly in livestock farming, where animal health management is critical
to maintaining the productivity and sustainability of the sector. The region’s
focus on innovative farming practices, precision livestock farming, and
biosecurity measures to prevent animal diseases is contributing to the demand
for veterinary services and products. Furthermore, the West is a hub for
biotechnology and pharmaceutical companies specializing in animal health,
leading to continuous innovation and the availability of advanced biologics,
diagnostics, and therapeutics. These factors, combined with strong consumer
awareness and a growing market for both companion animal and livestock health
products, make the West the fastest-growing region in the U.S. Animal Health
Market during the forecast period.
Major companies
operating in the U.S. Animal Health Market are:
- Zoetis Inc.
- Elanco Animal Health Inc.
- Ceva Animal Health, LLC
- Merck & Co., Inc.
- VETOQUINOL S.A.
- Boehringer Ingelheim International
GmbH
- Virbac S.A.
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals Plc
- Bimeda, Inc.
Download Free Sample Report
Customers can
also request 10% free customization on this report
“The U.S. Animal
Health Market is expanding due to the increasing awareness and adoption of
animal wellness programs that focus on holistic care. Many pet owners and
livestock farmers are now prioritizing not just treatment for diseases but also
proactive health management, which includes maintaining physical, mental, and
emotional well-being. This trend is fostering demand for a range of products,
including stress-relief treatments, joint care supplements, and behavioral
health solutions for pets. As a result, veterinary practices and product
manufacturers are incorporating wellness services, including fitness monitoring
and dietary counseling, into their offerings. The rise of comprehensive
wellness programs is a key factor driving growth in the U.S. Animal Health
Market.,” said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“U.S. Animal Health Market By Product
(Biologics, Pharmaceuticals, Medicinal Feed Additives, Others), By Animal Type
(Production Animals, Companion Animals), By Route of Administration (Oral,
Injectable, Intravenous, Topical, Others), By Disease (Porcine Diseases,
Poultry Diseases, Cattle Diseases, Aquaculture Diseases, Others), By
Distribution Channel (Retail, E-Commerce, Hospital/ Clinic Pharmacy), By
Region, Competition, Forecast and Opportunities, 2020-2030F”,
has evaluated the future growth potential of U.S. Animal Health Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision-makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in U.S. Animal Health Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com